| 9h30 - 10h30 |
Jurg Tschopp (University of Lausanne, Lausanne, Switzerland): The inflammasomes: Guardians of our body |
| 10h30 - 11h00 | Coffee break |
| 11h00 - 11h30 |
Young-Joon Surh (Seoul National University, Korea): Redox regulation of pro-inflammatory and anti-inflammatory signaling |
| 11h30 - 12h00 |
Massimo Locati (Fondazione Humanitas per la Ricerca, Rozzano, Italy): Signalling and adaptive responses via atypical chemokine receptor D6 |
| 12h00 - 12h30 |
Matthias Gaestel (Hannover Medical School, Germany): The role of MAPKAP kinases MK2 and MK3 in inflammation and beyond |
| 12h30 - 13h00 |
Thad Stappenbeck (Washington University, St Louis, USA): Role of epithelial growth factors in the maintenance of colonic homeostasis |
| 13h00 - 16h00 | Lunch, workshops and posters |
| Workshops | Posters |
|
14h00 - 15h00: Becton Dickinson 15h00 - 16h00: Promega |
14h00 - 16h00: Poster session |
| 16h00 - 16h30 |
Veronique Baud (Institut Cochin-INSERM U567, Paris, France): Novel roles of the alternative NF-kappaB pathway |
| 16h30 - 17h00 |
Rudi Beyaert (Ghent University - Department for Biomedical Molecular Biology, Belgium): The NF-κB inhibitor A20 as a peacekeeper in inflammation and immunity |
| 17h00 - 17h30 |
Hye-Kyung Na (Sungshin Women's University, Seoul, Korea): Role of IkappaB kinase in 4-Hydroxyestradiol-induced migration and transformation of human mammary epithelial cells |
| 17h30 - 18h00 |
Wouter de Jonge (Academic Medical Center, Amsterdam, The Netherlands): Acetylcholine modulates innate immune cell activation via Jak/Stat and NF-κB signaling pathways |
| 18h00 - 18h20 |
Roberto Gambari (Ferrara University, Italy): Decoy PNA-DNA-PNA chimeras targeting NF-κB transcription factors inhibit IL-8 gene expression in cystic fibrosis IB3-1 infected with Pseudomonas aeruginosa |
| 18h20 - 18h40 |
Emmanuel Dejardin (GIGA-Research, University of Liège, Belgium): TNFL-Induced p100 processing (TIPP) relies on the internalization of the cognate TNFR |
| 18h40 - 19h00 |
Hyeyoung Kim (Yonsei University, Seoul, Korea): Effect of lipid-associated membrane proteins from Mycoplasma pneumoniae on IL-8 expression in glutamine-deficient human alveolar epithelial A549 cells |
| 19h00 - 19h30 | Official talks and inauguration |
| 19h30 - 20h30 | Reception offered by the City of Luxembourg |
| 20h30 - 21h00 | Shuttles leave to the hotels from the meeting center |
| 8h30 - 9h00 |
Bharat B. Aggarwal (The University of Texas M. D. Anderson Cancer Center, USA): Targeting Inflammatory Pathways for Prevention and Treatment of Cancer |
| 9h00 - 9h30 |
Sankar Ghosh (Columbia University, New York, USA): Regulation of inflammatory signaling by TNF receptor |
| 9h30 - 10h00 |
Edward A. Dennis (University of California, USA): TLR4 Initiated Phospholipase A2 Signaling via Pro- and Anti- Inflammatory Eicosanoids |
| 10h00 - 10h30 |
Zigang Dong (Homel Institute, University of Minnesota, USA): Signal transduction in Solar UV-induced skin inflation and cancer |
| 10h30 - 11h00 | Coffee break |
| 11h00 - 11h30 |
Ajay Goel (Baylor University Medical Center, Dallas, USA): Epigenetic Changes by Dietary Agents |
| 11h30 - 12h00 |
Guy Haegeman (University of Ghent, Belgium): Impact of chromatin on inflammatory gene expression |
| 12h00 - 12h20 |
Jonathan Turner (Institute of Immunology, Luxembourg): Methylation of the (anti-inflammatory) glucocorticoid receptor promoter |
| 12h20 - 12h40 |
Oliver H. Krämer (Friedrich-Schiller-University Jena, Germany): Crosstalk between stimulated NF-κB and the tumor suppressor p53 |
| 12h40 - 13h00 |
Alexander Remels (Maastricht University, the Netherlands): TNF-α impairs regulation of skeletal muscle oxidative capacity through activation of NF-κB |
| Workshops | Posters |
|
13h00 - 14h00: IBA 14h00 - 15h00: Polyplus - Transfection 15h00 - 16h00: AMS Biotechnology |
14h00 - 16h00: Poster session |
| 16h00 - 16h30 |
Jacques Piette (Université de Liège, Belgium): Varicella-zoster virus interferes with innate immune signaling pathways |
| 16h30 - 17h00 |
Andrew Bowie (Trinity College Dublin, Ireland): Novel regulators of pattern recognition receptor signaling |
| 17h00 - 17h30 |
Christian Münz (University of Zürich, Switzerland): Priming of protective and tumor specific T cell responses in mice with human immune system component |
| 17h30 - 18h00 |
Johannes Bode (University of Düsseldorf, Germany): Role of the interplay of MK2 and MK3 for IRF3 dependent effects of LPS |
| 18h00 - 18h30 |
Yong Sang Song (Seoul National University, Korea): Human papillomavirus 16 E5 oncoprotein as an inducer of inflammatory cell signaling |
| 18h30 - 19h00 |
Stephen J. Galli (Stanford University, USA): Mast cells as negative regulators of innate and adaptive immune responses |
| 19h00 | Shuttles leave to the hotels from the meeting center |
| 8h30 - 9h00 |
Seth Masters (National Institutes of Arthritis and Musculoskeletal and Skin Diseases, USA): New additions and mechanistic insight into the spectrum of autoinflammatory disease |
| 9h00 - 9h30 |
Decio L. Eizirik (Université Libre de Bruxelles, Belgium): Signal transduction of inflammation-mediated beta-cell apoptosis in type 1 diabetes |
| 9h30 - 10h00 |
Sushovan Guha (M.D. Anderson Cancer Center, Houston, USA): G protein-coupled receptor mediated signaling pathways in pancreatic cancer |
| 10h00 - 10h30 |
Kapil Mehta (M.D. Anderson Cancer Center, Houston, USA): Tissue transglutaminase (TG2): a proinflammatory protein promotes cell survival and invasive signaling in cancer cells |
| 10h30 - 11h00 | Coffee break |
| 11h00 - 11h30 |
Sunil Krishnan (M.D. Anderson Cancer Center, Houston, USA): Targeting Inflammatory Pathways for Radiosensitization of Cancer |
| 11h30 - 11h50 |
Franck Morceau (LBMCC, Luxembourg): TNF alpha and anemia |
| 11h50 - 12h10 |
Malgorzata Rogalinska (Medical University of Vienna, Austria): Usefulness of differential scanning calorimetry for evaluation of treatment efficacy and development of personalized therapy of chronic lymphocytic leukemia |
| 12h10 - 12h30 |
Jenny E. Gumperz (University of Wisconsin School of Medicine and Public Health, USA): Recognition of Lyso-phosphatidylcholine by Human Natural Killer T Lymphocytes |
| 12h30 - 12h50 |
George Hajishengallis (University of Louisville, USA): Complement pathways involved in periodontal inflammation |
| 12h50 - 13h10 |
Salahaddin Mahmudi-Azer (University of Calgary, Alberta, Canada): Redefining Eosinophil Crystalloid Granules as a Potential New Functional Unit in Extracellular Inflammatory Events |
| 13h10 - 13h30 |
Alfonso Pompella (Dept. of Experimental Pathology, University of Pisa, Italy): A safe procedure® for measurment of S-nitrosoglutathione, the central metabolite in S-nitrosothiols formation and bioactivity |
| Workshops | Posters |
|
14h00 - 15h00: Bio-Rad 15h00 - 16h00: GE Healthcare |
14h00 - 16h00: Poster session |
| 16h00 - 16h30 |
Varsha Gandhi (M. D. Anderson Cancer Center, Houston, TX, USA): Targeting Bcl-2 Family Survival Proteins |
| 16h30 - 17h00 |
Peter Friedl (Radboud University Nijmegen Medical Centre, The Netherlands): Killing of cancer cells by CTL |
| 17h00 - 17h30 |
Ivana Scovassi (IGM-CNR, Pavia, Italy): PARP inhibitors: new tools to protect from inflammation |
| 17h30 - 17h50 |
Claudia Cerella (LBMCC, Luxembourg): Anti-apoptotic effect of COX2 inhibitors |
| 17h50 - 18h10 |
Alicia Torriglia (INSERM U 872, Paris, France): Glucocorticoides induce cell death in the retina |
| 18h10 - 18h30 |
Béatrice Charreau (Université de Nantes, France): Dysregulates Notch Signaling in Endothelial Cells: Implication of Notch2 and Notch4 to endothelial dysfunction |
| 18h30 - 18h50 |
Thomas Luft (German Cancer Research Center, Heidelberg, Germany): The second signal in antigen-presenting cells: Complementary JAK1 directs pro- and anti-inflammatory cytokine production induced by CD40L |
| 18h50 - 19h10 |
Iris Behrmann (Life Sciences Research Unit, University of Luxembourg): Hypoxia-inducible factor 1a is upregulated by Oncostatin M and participates in Oncostatin M signalling |
| 19h15 | Shuttles leave to the hotels from the meeting center |
| 8h30 - 9h00 |
Lina Ghibelli (University of Rome Tor Vergata, Italy): Novel signaling pathways induced by melatonin in leukocytes: inflammatory implications and pharmacological perspectives |
| 9h00 - 9h30 |
De-Xing Hou (Kagoshima University, Japan): Flavonoids as anti-inflammatory compounds: targeting signaling and molecules |
| 9h30 - 9h50 |
Norbert Latruffe (INSERM U 866; University of Burgundy, France): Responses of cell targets to resveratrol; involvement of common or separated mechanisms? |
| 9h50 - 10h10 |
Francesco Peri (University of Milano Bicocca, Italy): A chemical genetic approach to the study of the TLR4 pathway: new chemical entities targeting selectively the CD14 and MD-2 receptors |
| 10h10 - 10h30 |
Flavia Radogna (University of Rome Tor Vergata, Italy): Interference between nitric oxide synthase and lipoxygenase pathways leads to reciprocal abrogation of the effects of melatonin and magnetic fields in leukocytes |
| 10h30 - 11h00 | Coffee break |
| 11h00 - 11h20 |
Assam El-Osta (Baker IDI Heart and Diabetes Institute, Melbourne, Australia): The legacy of hyperglycemia is associated with persistent gene-activating epigenetic marks on the NF-κB-p65 gene |
| 11h20 - 11h40 |
Marc Schumacher (LBMCC, Luxembourg): Marine compounds as anti-inflammatory and anti-cancer agents |
| 11h40 - 12h00 |
Veera R. Konda (KinDex Therapeutics, USA): Substituted 1,3-cyclopentadiones analogues differentially inhibit inflammation in vitro and collagen-induced arthritis in mice |
| 12h00 - 12h20 |
Józefa Wesierska-Gadek (Medical University of Vienna, Austria): Impact of selective CDK inhibitors on functional status of cellular factors promoting survival of cancer cells |
| 12h20 - 12h40 |
Dietmar Fuchs University (Clinics, Innsbruck, Austria): In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors |
| 12h40 - 13h00 |
Stephan Immenschuh (Justus-Liebig-University Giessen, Giessen, Germany): Inhibition and genetic deficiency of p38 MAPK induces the anti-inflammatory heme oxygenase-1 gene via the redox-regulated transcription factor Nrf2 in macrophages |
| 13h00 - 14h00 | Lunch and end of the meeting |
| 14h00 | Shuttles leave to the hotels from the meeting center |